Sutro Biopharma, Inc. (STRO) shares rallied 5.9% in the last trading session to close at $15.8. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 43.7% gain over the past four weeks.The sudden stock price gain can be attributed to a positive investor mindset surrounding the potential of Sutro Biopharma’s wholly-owned oncology pipeline, which currently comprises one clinical-stage candidate, STRO-004, being deve ...